Anna Bersano

Summary

Publications

  1. request reprint
    Bersano A, Debette S, Zanier E, Lanfranconi S, De Simoni M, Zuffardi O, et al. The genetics of small-vessel disease. Curr Med Chem. 2012;19:4124-41 pubmed
    ..Large collaborative efforts and robust replication, as well as implementation of new genetic approaches, are necessary to identify genetic susceptibility factors for complex SVD. ..
  2. Bersano A, Ranieri M, Ciammola A, Cinnante C, Lanfranconi S, Dotti M, et al. Considerations on a mutation in the NOTCH3 gene sparing a cysteine residue: a rare polymorphism rather than a CADASIL variant. Funct Neurol. 2012;27:247-52 pubmed
  3. request reprint
    Bersano A, Borellini L, Motto C, Lanfranconi S, Pezzini A, Basilico P, et al. Molecular basis of young ischemic stroke. Curr Med Chem. 2013;20:3818-39 pubmed
    ..Since stroke is a potentially preventable disease, the identification of genes associated with young stroke may promote novel prevention strategies and allow the identification of therapeutic disease targets. ..
  4. Candelise L, Gattinoni M, Bersano A. Telephone audit for monitoring stroke unit facilities: a post hoc analysis from PROSIT study. J Stroke Cerebrovasc Dis. 2015;24:196-200 pubmed publisher
    ..However, a reliable description of the process of care and diagnostic investigations indicators should be obtained by either local site audit visit or prospective stroke register based on individual patient data. ..
  5. Bersano A, Zuffardi O, Pantoni L, Quaglini S, Ciccone R, Vetro A, et al. Next generation sequencing for systematic assessment of genetics of small-vessel disease and lacunar stroke. J Stroke Cerebrovasc Dis. 2015;24:759-65 pubmed publisher
    ..A translational approach combining a systematic genetic screening with a detailed phenotyping may facilitate the discovery of genetic basis and improve our knowledge in the pathogenesis of SVD. ..
  6. Ranieri M, Finsterer J, Bedini G, Parati E, Bersano A. Takotsubo Syndrome: Clinical Features, Pathogenesis, Treatment, and Relationship with Cerebrovascular Diseases. Curr Neurol Neurosci Rep. 2018;18:20 pubmed publisher
    ..Given its possible complications, including the association with neurological diseases, both cardiologist and neurologists should be aware about TTS in order to diagnose it promptly and to initiate appropriate therapeutic measures. ..
  7. Bersano A, Morbin M, Ciceri E, Bedini G, Berlit P, Herold M, et al. The diagnostic challenge of Divry van Bogaert and Sneddon Syndrome: Report of three cases and literature review. J Neurol Sci. 2016;364:77-83 pubmed publisher
    ..The report of our cases and the literature review underline the necessity of a detailed work-up and the collection of larger series to better clarify the DBS and SS phenotype and course. ..
  8. Bersano A, Lanfranconi S, Valcarenghi C, Bresolin N, Micieli G, Baron P. Neurological features of Fabry disease: clinical, pathophysiological aspects and therapy. Acta Neurol Scand. 2012;126:77-97 pubmed publisher
    ..This review focuses on central and peripheral nervous system involving available diagnostic tools and diagnostic work up in Fabry disease. It also covers the most recent evidence regarding enzyme replacement therapy. ..
  9. Bersano A, Bedini G, Oskam J, Mariotti C, Taroni F, Baratta S, et al. CADASIL: Treatment and Management Options. Curr Treat Options Neurol. 2017;19:31 pubmed publisher
    ..Further in vivo studies as well as data aggregation and multi-centre controlled clinical trials are needed to confirm the emerging findings in order to identify evidence-based therapies for CADASIL. ..